Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 628 JPY -0.11%
Market Cap: 620.7B JPY

Intrinsic Value

The intrinsic value of one Rohto Pharmaceutical Co Ltd stock under the Base Case scenario is hidden JPY. Compared to the current market price of 2 628 JPY, Rohto Pharmaceutical Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Rohto Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Rohto Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Rohto Pharmaceutical Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Rohto Pharmaceutical Co Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Rohto Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Rohto Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Rohto Pharmaceutical Co Ltd.

Explain Valuation
Compare Rohto Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Rohto Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Rohto Pharmaceutical Co Ltd

Current Assets 222.2B
Cash & Short-Term Investments 78.2B
Receivables 71.8B
Other Current Assets 72.2B
Non-Current Assets 217.7B
Long-Term Investments 49.5B
PP&E 88.9B
Intangibles 67.8B
Other Non-Current Assets 11.5B
Current Liabilities 102.3B
Accounts Payable 22.2B
Accrued Liabilities 21.8B
Other Current Liabilities 58.3B
Non-Current Liabilities 62.4B
Long-Term Debt 26.9B
Other Non-Current Liabilities 35.5B
Efficiency

Free Cash Flow Analysis
Rohto Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Rohto Pharmaceutical Co Ltd

Revenue
333.8B JPY
Cost of Revenue
-146.2B JPY
Gross Profit
187.6B JPY
Operating Expenses
-147.1B JPY
Operating Income
40.5B JPY
Other Expenses
-4.7B JPY
Net Income
35.7B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Rohto Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive 3Y Average ROE
Positive 3Y Average ROIC
hidden
Profitability
Score

Rohto Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Rohto Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
High Altman Z-Score
Negative Net Debt
hidden
Solvency
Score

Rohto Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Rohto Pharmaceutical Co Ltd

Wall Street analysts forecast Rohto Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Rohto Pharmaceutical Co Ltd is 2 977.27 JPY with a low forecast of 2 424 JPY and a high forecast of 3 675 JPY.

Lowest
Price Target
2 424 JPY
8% Downside
Average
Price Target
2 977.27 JPY
13% Upside
Highest
Price Target
3 675 JPY
40% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Rohto Pharmaceutical Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Rohto Pharmaceutical Co Ltd stock?

The intrinsic value of one Rohto Pharmaceutical Co Ltd stock under the Base Case scenario is hidden JPY.

Is Rohto Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 2 628 JPY, Rohto Pharmaceutical Co Ltd is hidden .

Back to Top